Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Phillip W. Carrott"'
Autor:
Nihanth Palivela, Eugene Choi, Phillip W. Carrott, Bryan M. Burt, Taylor Splawn, R. Taylor Ripley, Lorraine D. Cornwell, George Van Buren, David J. Sugarbaker, Shawn S. Groth
Publikováno v:
The Annals of Thoracic Surgery. 112:1568-1574
Background With a multimodal treatment strategy, cytoreductive surgery extends survival in malignant pleural mesothelioma. Improving the accuracy of staging can refine patient selection. Our objective was to determine whether diagnostic laparoscopy (
Autor:
Farhood Farjah, Nader N. Massarweh, Xiangjun Gu, Phillip W. Carrott, Robert T. Ripley, Shawn S. Groth, Wilson Luiz da Costa, Bryan M. Burt
Publikováno v:
The Annals of thoracic surgery. 113(1)
Background Treatment selection for patients with esophageal adenocarcinoma is predicated on clinical staging information, which is inaccurate in 20% to 30% of cases and could impact the delivery of guideline-concordant treatment. We aimed to evaluate
Autor:
Richard S. Kwon, Erik Jan Wamsteker, Andrew C. Chang, Phillip W. Carrott, Andrew P. Wright, Aarti Oza Bedi, B. Joseph Elmunzer, Ryan Law, Grace H. Elta
Publikováno v:
Surgical Endoscopy. 31:3489-3494
Esophageal fully covered self-expandable metal stents (FCSEMS) are indicated for the management of benign and malignant conditions of the esophagus including perforations, leaks, and strictures. FCSEMS are resistant to tissue ingrowth and are removab
Autor:
Phillip W. Carrott, Robert G. Martindale, Laszlo N. Kiraly, Jayshil J. Patel, Martin D. Rosenthal
Publikováno v:
The Journal of Nutrition. 146:2594S-2600S
Arginine supplementation has the potential to improve the health of patients. Its use in hospitalized patients has been a controversial topic in the nutrition literature, especially concerning supplementation of septic patients. In this article, we r
Autor:
Arlene M. Correa, Thomas A. D'Amico, Steven R. DeMeester, Thomas J. Watson, Mark B. Orringer, J. J. B. van Lanschot, Nabil P. Rizk, Stephen G. Swisher, Alex G. Little, James D. Luketich, Lorenzo E. Ferri, P. Nafteux, Nassar K. Altorki, Antoon Lerut, Wayne L. Hofstetter, Phillip W. Carrott, J. H. Peters, Traves D. Crabtree, Stephen C. Yang, Eugene H. Blackstone, Henner Schmidt, Paul M. Schneider, Johnny Moons, Scott M. Atay, Jaffer A. Ajani, Daniel Vallböhmer, Andrew C. Chang, Mark J. Krasna, Jarmo A. Salo, Shanda H. Blackmon, Bernard Mark Smithers, Stephanie G. Worrell, Thomas W. Rice, Thomas R. DeMeester, Donald E. Low, Henning A. Gaissert, Daniel L. Miller, Gail Darling, Thomas K. Varghese, Katie S. Nason
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 157:1264-1272.e6
Objective Clinical T2N0 esophageal carcinoma is a heterogenous disease frequently complicated by inaccurate staging. Incorrect staging may lead to suboptimal treatment for patients with unidentified local-regionally advanced disease. Therapeutic opti
Autor:
Rishindra M. Reddy, Andrew C. Chang, Phillip W. Carrott, Vasudha Murlidhar, Sunitha Nagrath, Zhuo Zhang, Nithya Ramnath, Jules Lin, Mark B. Orringer, Lili Zhao, David G. Beer, William R. Lynch, Svetlana Grabauskiene
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 151(3)
Objective To identify circulating tumor cells (CTCs) in the blood of patients with early-stage lung cancer and to show that sampling pulmonary vein (PV) blood using microfluidic chip technology will yield significantly more CTCs. Improving early dete